Identification of a pre-active conformation of a pentameric channel receptor

  1. Anaïs Menny
  2. Solène N Lefebvre
  3. Philipp AM Schmidpeter
  4. Emmanuelle Drège
  5. Zaineb Fourati
  6. Marc Delarue
  7. Stuart J Edelstein
  8. Crina M Nimigean
  9. Delphine Joseph
  10. Pierre-Jean Corringer  Is a corresponding author
  1. Institut Pasteur, France
  2. Weill Cornell Medicine, United States
  3. Université Paris-Sud, France
  4. Inserm U1024, CNRS 8197, Institute of Biology, Ecole Normale Supérieure, France

Abstract

Pentameric ligand-gated ion channels (pLGICs) mediate fast chemical signalling through global allosteric transitions. Despite the existence of several high-resolution structures of pLGICs, their dynamical properties remain elusive. Using the proton-gated channel GLIC, we engineered multiple fluorescent reporters, each incorporating a bimane and a tryptophan/tyrosine, whose close distance causes fluorescence quenching. We show that proton application causes a global compaction of the extracellular subunit interface, coupled to an outward motion of the M2-M3 loop near the channel gate. These movements are highly similar in lipid vesicles and detergent micelles. These reorganizations are essentially completed within 2 ms and occur without channel opening at low proton concentration, indicating that they report a pre-active intermediate state in the transition pathway towards activation. This provides a template to investigate the gating of eukaryotic neurotransmitter receptors, for which intermediate states also participate in activation.

Article and author information

Author details

  1. Anaïs Menny

    Channel Receptors Unit, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Solène N Lefebvre

    Channel Receptors Unit, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Philipp AM Schmidpeter

    Department of Anesthesiology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Emmanuelle Drège

    BioCIS, Université Paris-Sud, Châtenay-Malabry, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Zaineb Fourati

    Unité de Dynamique Structurale des Macromolécules, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Marc Delarue

    Unité de Dynamique Structurale des Macromolécules, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Stuart J Edelstein

    Biologie Cellulaire de la Synapse, Inserm U1024, CNRS 8197, Institute of Biology, Ecole Normale Supérieure, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Crina M Nimigean

    Department of Anesthesiology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Delphine Joseph

    BioCIS, Université Paris-Sud, Châtenay-Malabry, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Pierre-Jean Corringer

    Channel Receptors Unit, Institut Pasteur, Paris, France
    For correspondence
    pjcorrin@pasteur.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4770-430X

Funding

Agence Nationale de la Recherche (Pentagate)

  • Anaïs Menny
  • Solène N Lefebvre
  • Emmanuelle Drège
  • Zaineb Fourati
  • Marc Delarue
  • Delphine Joseph
  • Pierre-Jean Corringer

Centre National de la Recherche Scientifique (UMR 3571)

  • Anaïs Menny
  • Solène N Lefebvre
  • Delphine Joseph

Institut Pasteur

  • Anaïs Menny
  • Solène N Lefebvre
  • Zaineb Fourati
  • Marc Delarue
  • Pierre-Jean Corringer

Université Pierre et Marie Curie (PhD student fellowship)

  • Anaïs Menny
  • Solène N Lefebvre

Fondation pour la Recherche Médicale (DEQ20140329497)

  • Anaïs Menny
  • Pierre-Jean Corringer

National Institutes of Health (R01 GM088352)

  • Crina M Nimigean

Centre National de la Recherche Scientifique (UMR 8076)

  • Emmanuelle Drège
  • Delphine Joseph

Centre National de la Recherche Scientifique (UMR 3528)

  • Zaineb Fourati
  • Marc Delarue

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Menny et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,045
    views
  • 526
    downloads
  • 43
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anaïs Menny
  2. Solène N Lefebvre
  3. Philipp AM Schmidpeter
  4. Emmanuelle Drège
  5. Zaineb Fourati
  6. Marc Delarue
  7. Stuart J Edelstein
  8. Crina M Nimigean
  9. Delphine Joseph
  10. Pierre-Jean Corringer
(2017)
Identification of a pre-active conformation of a pentameric channel receptor
eLife 6:e23955.
https://doi.org/10.7554/eLife.23955

Share this article

https://doi.org/10.7554/eLife.23955

Further reading

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.